Page last updated: 2024-11-01

ofloxacin and Cancer of Mouth

ofloxacin has been researched along with Cancer of Mouth in 1 studies

Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.

Research Excerpts

ExcerptRelevanceReference
"A possible case of levofloxacin-induced thrombocytopenia is reported."7.77Possible case of levofloxacin-induced thrombocytopenia. ( Liu, CY; Salloum, R; Weise, AM, 2011)
"A possible case of levofloxacin-induced thrombocytopenia is reported."3.77Possible case of levofloxacin-induced thrombocytopenia. ( Liu, CY; Salloum, R; Weise, AM, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Salloum, R1
Liu, CY1
Weise, AM1

Other Studies

1 other study available for ofloxacin and Cancer of Mouth

ArticleYear
Possible case of levofloxacin-induced thrombocytopenia.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2011, Jan-01, Volume: 68, Issue:1

    Topics: Aged; Anti-Bacterial Agents; Carcinoma, Squamous Cell; Female; Humans; Levofloxacin; Mouth Neoplasms

2011